Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.96 +0.39 (+24.84%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nautilus Biotechnology (NAUT) Return on Capital Employed [ROCE] (2026)

Updated

Nautilus Biotechnology's Return on Capital Employed [ROCE] came in at -21.49% for Q2 2026.

Analysis

Nautilus Biotechnology (NAUT) Return on Capital Employed [ROCE] (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 8.30%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 7.98%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 6.42%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 18.58%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 8.34%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 13.69%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 10.83%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 11.99%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 6.00%
10 Nautilus Biotechnology 249.36 Mn 249.36 Mn 175,000.00 -21.49%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.49%
API Access

Nautilus Biotechnology Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NAUT&period=max&api_key=YOUR_API_KEY